Trials / Recruiting
RecruitingNCT04172753
Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 472 (estimated)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Detailed description
Novel hybrid devices combine magnetic resonance imaging (MRI) and a linear accelerator in a single device. The superior soft tissue contrast compared with cone-beam computed tomography based treatment and the possibility for daily plan adaptation promise a higher precision of treatment, better target volume coverage and normal tissue sparing. In a first step the present study will test the feasibility of imaging and treatment on the 1.5 T MR-Linac.
Conditions
- Rectal Cancer
- Head and Neck Cancer
- Liver Cancer
- Breast Cancer
- Prostate Cancer
- Oligometastasis
- Esophageal Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy on the MR-Linac | Radiotherapy is performed on the 1.5 T MR Linac |
| DIAGNOSTIC_TEST | Imaging on the MR Linac | Only imaging performed on the MR Linac |
Timeline
- Start date
- 2018-05-09
- Primary completion
- 2022-05-09
- Completion
- 2027-05-09
- First posted
- 2019-11-21
- Last updated
- 2019-11-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04172753. Inclusion in this directory is not an endorsement.